Publication | Closed Access
Hesperidin attenuates mitochondrial dysfunction during benzo(a)pyrene-induced lung carcinogenesis in mice
41
Citations
40
References
2010
Year
Lung InflammationMitochondrial DysfunctionLipid PeroxidationPathologyRedox BiologyMitochondrial StatusToxicological MechanismOxidative StressRespiratory ToxicologyPulmonary PharmacologyToxicologyHepatotoxicityMitochondrial AbnormalitiesBiochemistryReactive Oxygen SpecieMetabolomicsPharmacologyLung CancerMitochondrial FunctionLung CarcinogenesisPhysiologyMetabolismMedicine
The present study is designed to assess the mitochondrial status during benzo(a)pyrene (B(a)P)-induced lung carcinogenesis in Swiss albino mice and to reveal the modulatory effect of hesperidin over it. B(a)P (50 mg/kg body weight)-induced mitochondrial abnormalities was evident from alterations in mitochondrial lipid peroxides, antioxidant status (superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, reduced glutathione, vitamin E, and vitamin C), major tricarboxylic acid (TCA) cycle enzyme activities (isocitrate dehydrogenase, succinate dehydrogenase, malate dehydrogenase, alpha-ketoglutarate dehydrogenase), electron transport chain (ETC) complexes activities and ATP levels. Ultrastructural changes in lung mitochondria were also in accord with the above aberrations. Hesperidin (25 mg/kg body weight) supplementation effectively counteracted all the above changes and restored cellular normalcy, indicating its protective role during B(a)P-induced lung cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1